CLN6 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP9612b
Background:
This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
Other Names:
Ceroid-lipofuscinosis neuronal protein 6, Protein CLN6, CLN6
Gene Name: CLN6
Gene ID: 54982
Primary Accession: Q9NWW5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
Other Names:
Ceroid-lipofuscinosis neuronal protein 6, Protein CLN6, CLN6
Gene Name: CLN6
Gene ID: 54982
Primary Accession: Q9NWW5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review